— Know what they know.
Not Investment Advice
Also trades as: 6849.T (JPX) · $vol 7M · NHNKF (OTC) · $vol 0M

NHNKY OTC

Nihon Kohden Corporation
1W: -2.6% 1M: +4.2% 3M: +7.1% YTD: -11.0% 1Y: -17.1% 3Y: -17.4% 5Y: -40.7%
$9.91
-0.15 (-1.47%)
 
Weekly Expected Move ±3.5%
$9 $10 $10 $10 $11
OTC · Healthcare · Medical - Devices · Tech Score Buy · Power 69 · $3.2B mcap · 316M float · 0.0059% daily turnover · Short 36% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$3.2B
52W Range8.12-14.21
Volume1,000
Avg Volume18,566
Beta0.38
Dividend$0.20
Analyst Ratings
No analyst coverage
Company Info
CEOHirokazu Ogino
Employees6,116
SectorHealthcare
IndustryMedical - Devices
IPO Date2013-09-27
1-31-4 Nishiochiai
Tokyo, TY 161-8560
JP
81 3 5996 8036
About Nihon Kohden Corporation

Nihon Kohden Corporation specializes in the comprehensive lifecycle of medical electronic equipment, from research and development and manufacturing to sales, repair, and ongoing maintenance. The company operates across a global footprint encompassing Japan, the Americas, Europe, and the wider Asian market, as well as other international regions. Their diverse product portfolio includes advanced physiological measurement devices such as electroencephalographs (EEGs), electrocardiographs (ECGs), evoked potential and electromyogram instruments, and polygraphs tailored for catheterization laboratories. These are often complemented by sophisticated diagnostic information systems, along with essential consumables like recording papers, electrodes, and various catheters, supported by comprehensive maintenance services. The company also delivers complete patient monitoring solutions, which encompass central, bedside, and wireless monitors, remote access software, and associated clinical information systems. These systems utilize critical consumables like specialized electrodes and sensors. Furthermore, Nihon Kohden offers a range of therapeutic devices, including life-saving defibrillators (both manual and automated external defibrillators or AEDs), ventilators, pacemakers, anesthesia machines, and cochlear implants. These are supplied with necessary consumables, such as AED pads and batteries, and accompanying support services. Their offerings extend to other specialized medical apparatus, such as hematology and clinical chemistry analyzers, ultrasound diagnostic units, and equipment designed for research purposes. Crucially, these are supported by specific consumables like test reagents, alongside installation and ongoing maintenance services. Beyond its core medical device operations, the corporation also holds interests in insurance brokerage and technology licensing. Established in 1951, the company maintains its headquarters in Tokyo, Japan.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms